Literature DB >> 27526707

Paraprotein-Related Kidney Disease: Kidney Injury from Paraproteins-What Determines the Site of Injury?

Mona Doshi1, Amit Lahoti2, Farhad R Danesh2, Vecihi Batuman3,4, Paul W Sanders5,6,7.   

Abstract

Disorders of plasma and B cells leading to paraproteinemias are associated with a variety of renal diseases. Understanding the mechanisms of injury and associated nephropathies provides a framework that aids clinicians in prompt diagnosis and appropriate adjunctive treatment of these disorders. Glomerular diseases that may be associated with paraproteinemias include amyloid deposition, monoclonal Ig deposition disease, proliferative GN with monoclonal Ig deposits, C3 glomerulopathy caused by alterations in the complement pathway, immunotactoid glomerulopathy, fibrillary GN, and cryoglobulinemia. Tubular lesions include the classic Fanconi syndrome, light-chain proximal tubulopathy, interstitial fibrosis, and cast nephropathy. These paraproteinemic renal diseases are distinct in their pathogenesis as well as their urinary and kidney biopsy findings. Renal pathology is usually initiated by deposition and direct involvement of the intact monoclonal Ig or Ig fragments with resident cells of the nephron. Our review summarizes current insights into the underlying molecular pathogenesis of these interesting kidney lesions.
Copyright © 2016 by the American Society of Nephrology.

Entities:  

Keywords:  Kidney Diseases; Myeloma Proteins; Paraproteins; amyloidosis; glomerular disease; immunoglobulin free light chains; immunoglobulins; kidney; multiple myeloma; multiple myeloma M-proteins; paraproteins; tubular epithelium

Mesh:

Substances:

Year:  2016        PMID: 27526707      PMCID: PMC5142058          DOI: 10.2215/CJN.02560316

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  53 in total

1.  Somatic mutations of the L12a gene in V-kappa(1) light chain deposition disease: potential effects on aberrant protein conformation and deposition.

Authors:  R Vidal; F Goñi; F Stevens; P Aucouturier; A Kumar; B Frangione; J Ghiso; G Gallo
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

2.  An animal model of glomerular light-chain-associated amyloidogenesis depicts the crucial role of lysosomes.

Authors:  Jiamin Teng; Elba A Turbat-Herrera; Guillermo A Herrera
Journal:  Kidney Int       Date:  2014-04-30       Impact factor: 10.612

3.  More light shed on light chains.

Authors:  Paisit Paueksakon; Agnes B Fogo
Journal:  Nephrol Dial Transplant       Date:  2014-06-03       Impact factor: 5.992

4.  Pathophysiology of acute Bence-Jones protein nephrotoxicity in the rat.

Authors:  J H Weiss; R H Williams; J H Galla; J L Gottschall; E D Rees; D Bhathena; R G Luke
Journal:  Kidney Int       Date:  1981-08       Impact factor: 10.612

5.  Dense deposit disease associated with monoclonal gammopathy of undetermined significance.

Authors:  Sanjeev Sethi; William R Sukov; Yuzhou Zhang; Fernando C Fervenza; Donna J Lager; Dylan V Miller; Lynn D Cornell; Srivilliputtur G Santhana Krishnan; Richard J H Smith
Journal:  Am J Kidney Dis       Date:  2010-09-15       Impact factor: 8.860

6.  Nodular glomerulosclerosis with deposition of monoclonal immunoglobulin heavy chains lacking C(H)1.

Authors:  B Moulin; S Deret; X Mariette; O Kourilsky; H Imai; L Dupouet; L Marcellin; I Kolb; P Aucouturier; J C Brouet; P M Ronco; B Mougenot
Journal:  J Am Soc Nephrol       Date:  1999-03       Impact factor: 10.121

7.  Nephrotoxic potential of Bence Jones proteins.

Authors:  A Solomon; D T Weiss; A A Kattine
Journal:  N Engl J Med       Date:  1991-06-27       Impact factor: 91.245

8.  Immunoglobulin light (heavy)-chain deposition disease: from molecular medicine to pathophysiology-driven therapy.

Authors:  Pierre Ronco; Emmanuelle Plaisier; Béatrice Mougenot; Pierre Aucouturier
Journal:  Clin J Am Soc Nephrol       Date:  2006-10-11       Impact factor: 8.237

9.  Pathogenesis of glomerulosclerosis in light chain deposition disease. Role for transforming growth factor-beta.

Authors:  L Zhu; G A Herrera; J E Murphy-Ullrich; Z Q Huang; P W Sanders
Journal:  Am J Pathol       Date:  1995-08       Impact factor: 4.307

10.  Glomerular expression of matrix metalloproteinases in AL-amyloidosis and association with renal function at the time of kidney biopsy.

Authors:  Evangelia Charitaki; Efstathios Kastritis; Constantina Petraki; Konstantinos Liapis; Konstantinos Adamidis; Theophanis Apostolou; Christallenia Christodoulidou; Nikoleta Nikolopoulou; Evangelos Terpos; Lydia Nakopoulou; Meletios A Dimopoulos
Journal:  Clin Nephrol       Date:  2016-01       Impact factor: 0.975

View more
  15 in total

Review 1.  Pathophysiology and management of monoclonal gammopathy of renal significance.

Authors:  Ankur Jain; Richard Haynes; Jaimal Kothari; Akhil Khera; Maria Soares; Karthik Ramasamy
Journal:  Blood Adv       Date:  2019-08-13

2.  Paraprotein-Related Kidney Disease: Attack of the Killer M Proteins.

Authors:  Mark A Perazella; Kevin W Finkel
Journal:  Clin J Am Soc Nephrol       Date:  2016-12-07       Impact factor: 8.237

3.  Proliferative glomerulonephritis with unusual microlamellar organized deposits related to monoclonal immunoglobulin G3 (IgG3) kappa.

Authors:  Akiko Mii; Akira Shimizu; Daisuke Takada; Shuichi Tsuruoka
Journal:  CEN Case Rep       Date:  2018-07-09

Review 4.  Dominant C3 glomerulopathy: new roles for an old actor in renal pathology.

Authors:  Nicola Pirozzi; Antonella Stoppacciaro; Paolo Menè
Journal:  J Nephrol       Date:  2017-11-18       Impact factor: 3.902

5.  Free light chains injure proximal tubule cells through the STAT1/HMGB1/TLR axis.

Authors:  Rohit Upadhyay; Wei-Zhong Ying; Zannatul Nasrin; Hana Safah; Edgar A Jaimes; Wenguang Feng; Paul W Sanders; Vecihi Batuman
Journal:  JCI Insight       Date:  2020-07-23

6.  Coexistent light chain deposition disease, light chain cast nephropathy, and vascular light chain amyloidosis in a patient with IgD lambda multiple myeloma.

Authors:  Zi-Shan Lin; Xiao-Juan Yu; Ai-Bo Qin; Meng-Yao Liu; Su-Xia Wang; Fu-De Zhou; Ming-Hui Zhao
Journal:  Int Urol Nephrol       Date:  2021-01-06       Impact factor: 2.370

7.  Kidney Biopsy in Patients With Monoclonal Gammopathy: A Multicenter Retrospective Cohort Study.

Authors:  Sheng Nie; Mengyi Wang; Qijun Wan; Yaozhong Kong; Jun Ou; Nan Jia; Xiaodong Zhang; Fan Luo; Xiaoting Liu; Lin Wang; Yue Cao; Ruixuan Chen; Mingpeng Zhao; David Yiu Leung Chan; Guobao Wang
Journal:  Front Med (Lausanne)       Date:  2021-05-24

8.  Multiple morphological phenotypes of monoclonal immunoglobulin disease on renal biopsy: Significance of treatment.

Authors:  Sreedhar Adapa; Venu Madhav Konala; Srikanth Naramala; Cynthia C Nast
Journal:  Clin Nephrol Case Stud       Date:  2020-04-17

Review 9.  Novel Insights into Crystal-Induced Kidney Injury.

Authors:  Shrikant R Mulay; Chongxu Shi; Xiaoyuan Ma; Hans Joachim Anders
Journal:  Kidney Dis (Basel)       Date:  2018-04-03

10.  Membranous Glomerulopathy With Light Chain-Restricted Deposits: A Clinicopathological Analysis of 28 Cases.

Authors:  Alejandro Best Rocha; Christopher P Larsen
Journal:  Kidney Int Rep       Date:  2017-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.